PAMU
SGNT

Pictet Asset Management (UK)’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Pictet Asset Management (UK)’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-112,200
Closed -$1.45M – 866
2016
Q2 		$1.45M Hold
112,200
– – 0.01% 771
2016
Q1 		$1.59M Hold
112,200
– – 0.01% 719
2015
Q4 		$1.78M Buy
112,200
+25,300
+29% +$398K 0.01% 737
2015
Q3 		$1.33M Buy
86,900
+19,700
+29% +$426K 0.01% 760
2015
Q2 		$1.65M Sell
67,200
-637,114
-90% -$15.3M 0.01% 762
2015
Q1 		$16.4M Buy
704,314
+681,714
+3,016% +$18M 0.07% 333
2014
Q4 		$568K Sell
22,600
-800
-3% -$23.5K ﹤0.01% 827
2014
Q3 		$728K Sell
23,400
-3,200
-12% -$86.7K ﹤0.01% 811
2014
Q2 		$688K Buy
26,600
+1,000
+4% +$22.2K ﹤0.01% 812
2014
Q1 		$598K Buy
25,600
+2,700
+12% +$59K ﹤0.01% 810
2013
Q4 		$581K Sell
22,900
-6,100
-21% -$138K ﹤0.01% 805
2013
Q3 		$592K Buy
29,000
+3,300
+13% +$73.5K ﹤0.01% 801
2013
Q2 		$539K Buy
+25,700
New +$459K ﹤0.01% 802

Pictet Asset Management (UK)'s SGNT Position: Q3 2016 in Review

Pictet Asset Management (UK) sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 112,200 shares — an estimated $1.45M sold.

Pictet Asset Management (UK) first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $16.4M in Q1 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Pictet Asset Management (UK) reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 112,200 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.45M.
  • Pictet Asset Management (UK) first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • Pictet Asset Management (UK)'s SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $16.4M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2016, filed 14 Nov 2016.